MIRF research output · UBC

Publications

Peer-reviewed work in nuclear imaging, radiochemistry, drug delivery, and theranostics — from MIRF and collaborators across academia and industry.

63publications
2014–2026year span
10+application areas
Open journal pages
Year
Application
Isotope
Modality
Showing 61 of 61 publications

No publications match these filters.
Try removing some filters or clearing the search.

#63
2026197HgTheranosticsRadiochemistrySPECTDual tracer

Bifunctional sulfur-rich macrocyclic chelators and their immunoconjugates for the targeted delivery of theranostic mercury-197

Randhawa P, Kondo M, Chu ACK, Rodríguez-Rodríguez C, Cai Z, Chan C, Ganga-Sah Y, Chen S, Weatherall N, Davey PRWJ, Merkens H, Reilly RM, Radchenko V, Ramogida CF
RSC Pharm · 2026 · Advance online publication
DOI
#62
2025203Pb212PbTheranosticsRadiochemistrySPECTDual tracer

Is Thiourea the Weak Link? An Investigation of the In Vitro and In Vivo Destabilization of [203Pb]- and [212Pb]Pb2+ Thiourea-Based Bioconjugates

McNeil BL, Wharton L, Chen CC, Merkens H, Čolović M, Rodríguez-Rodríguez C, Wilson J, Mair S, Zhang C, McDonagh AW, Lin KS, Bénard F, Wuest F, Schaffer P, Ramogida CF
ACS Bio Med Chem Au. · 2025 · Dec 8; 6(1):56-77
DOI
#61
2025197HgTheranosticsMethodsSPECTDual tracer

Quantitative dual-isotope preclinical SPECT/CT imaging and biodistribution of the mercury-197m/g theranostic pair

Randhawa P, Rodríguez-Rodríguez C, Koniar H, Davey PRWJ, Chen S, Radchenko V, Ramogida CF
EJNMMI Radiopharmacy and Chemistry · 2025 · Advance online publication
DOI
#60
202589Zr161Tb227ThRadiochemistryCancerPETSPECT

Synthesis and evaluation of HOPO-O8-methyl-tetrazine as a bifunctional chelator for use in [89Zr]Zr4+, [161Tb]Tb3+ and [227Th]Th4+ radioimmunoconjugates

Carbo-Bague I, Randhawa P, Tosato M, McNeil BL, Čolović M, London L, Rodríguez-Rodríguez C, Osooly M, Wharton L, Merkens H, Van De Voorde M, Ooms M, Yang H, Bénard F, Ramogida CF
Journal of Inorganic Biochemistry · 2025 · 250 · In press
DOI
#59
2025111InNanomedicineDrug deliverySPECT

Liposomal lipid nanoparticles for extrahepatic delivery of mRNA

Cheng MHY, Zhang Y, Fox K, Leung J, Strong C, Kang E, Chen Y, Tong M, Bommadevara H, Jan E, Ip OYL, Rodríguez-Rodríguez C, Saatchi K, Häfeli UO, Abdolahzadeh A, Witzigmann D, Cullis PR
Nature Communications · 2025 · 16 · Article 4135
DOI
#58
2025111In67GaNanomedicineDrug deliveryAntimicrobialPharmacokineticsSPECTDual tracer

Nanogel encapsulation improves pharmacokinetics and biodistribution of antimicrobial peptide LL37 upon lung deposition: In vivo evaluation by SPECT/CT

Kłodzińska SN, Esposito TVF, Agnoletti M, Rodríguez-Rodríguez C, Blackadar C, Wu L, Thakur A, Nahrstedt J, Rades T, Saatchi K, Häfeli UO, Nielsen HM
Journal of Controlled Release · 2025 · Advance online publication
DOI
#57
2025227ThTheranosticsRadiochemistryCancer

Chelating [227Th]Th4+ for peptide receptor radionuclide therapy of neuroendocrine tumours

Wharton L, McNeil SW, Meeres H, Zhang D, Ingham A, Merkens H, Osooly M, Rodríguez-Rodríguez C, Bénard F, Yang H
Bioconjugate Chemistry · 2025 · Advance online publication
DOI
#56
2024165ErTheranosticsMethodsCancerSPECT

First preclinical SPECT/CT imaging and biodistribution of [165Er]ErCl₃ and [165Er]Er-PSMA-617

Saeedi Saghez B, Rodríguez-Rodríguez C, Esquinas PL, Merkens H, Benard F, Radchenko V, Yang H
EJNMMI Radiopharmacy and Chemistry · 2024 · 9 · Article 90
DOI
#55
2024226AcTheranosticsMethodsSPECT

In vivo quantitative SPECT imaging of actinium-226: feasibility and proof-of-concept

Koniar H, Wharton L, Ingham A, Rodríguez-Rodríguez C, Kunz P, Radchenko V, Yang H, Rahmim A, Uribe C, Schaffer P
Physics in Medicine & Biology · 2024 · 69(15):155003
DOI
#54
2024155Tb161TbTheranosticsMethodsSPECT

Quantitative SPECT imaging of 155Tb and 161Tb for preclinical theranostic radiopharmaceutical development

Koniar H, McNeil S, Wharton L, Ingham A, Van de Voorde M, Ooms M, Sekar S, Rodríguez-Rodríguez C, Kunz P, Radchenko V, Rahmim A, Uribe C, Yang H, Schaffer P
EJNMMI Physics · 2024 · 11 · Article 77
DOI
#53
2024226AcTheranosticsMethodsCancerSPECT

Preclinical Evaluation of 226Ac as a Theranostic Agent: Imaging, Dosimetry, and Therapy

Koniar H, Wharton L, Ingham A, Morales Oliver AP, Merkens H, Rodríguez-Rodríguez C, Kunz P, Radchenko V, Yang H, Rahmim A, Uribe C, Schaffer P
Journal of Nuclear Medicine · 2024 · In press
DOI
#52
2024155Tb161TbTheranosticsCancerRadiochemistrySPECT

Preclinical evaluation of MC1R targeting theranostic pair [155Tb]Tb-crown-αMSH and [161Tb]Tb-crown-αMSH

Wharton L, McNeil SW, Zhang C, Engudar G, Van de Voorde M, Zeisler J, Koniar H, Sekar S, Yuan Z, Schaffer P, Radchenko V, Ooms M, Kunz P, Bénard F, Yang H
Nuclear Medicine and Biology · 2024 · 136–137:108925
DOI
#51
2024111In3HNanomedicineDrug deliveryInflammationSPECT

Prodrug Nanomedicine for Synovium Targeted Therapy of Inflammatory Arthritis: Insights from Animal Model and Human Synovial Joint Fluid

Nosrati Z, Chen YA, Bergamo M, Rodríguez-Rodríguez C, Chan J, Shojania K, Kherani RB, Chin C, Kelsall JT, Dehghan N, Colwill AM, Collins D, Saatchi K, Häfeli UO
Advanced Healthcare Materials · 2024 · 2401936
DOI
#50
202467GaAntimicrobialPharmacokineticsDrug deliverySPECT

Biodistribution of the cationic host defense peptide LL-37 using SPECT/CT

Esposito TVF, Rodríguez-Rodríguez C, Blackadar C, Kłodzińska S, Mørck Nielsen H, Saatchi K, Häfeli UO
European Journal of Pharmaceutics and Biopharmaceutics · 2024 · 114398
DOI
#49
202467GaAntimicrobialNanomedicinePharmacokineticsSPECT

Biodistribution of native and nano-formulated Innate Defense Regulator (IDR) peptide 1002

Esposito TVF, Blackadar C, Wu L, Rodríguez-Rodríguez C, Haney EF, Pletzer D, Saatchi K, Hancock REW, Häfeli UO
Molecular Pharmaceutics · 2024 · 21:2751–2766
DOI
#48
202499mTcMethodsRadiochemistrySPECT

Development of a 99mTc-labeled tetrazine for pretargeted SPECT imaging using an alendronic acid-based bone targeting model

Bohrmann L, Poulie CBM, Rodríguez-Rodríguez C, Karagiozov S, Saatchi K, Herth MM, Häfeli UO
PLoS ONE · 2024 · 19(4):e0300466
DOI
#47
2024111InDrug deliveryInflammationSPECT

Intranasal delivery of low-dose anti-CD124 antibody enhances the treatment of chronic rhinosinusitis with nasal polyps

Wu J, Jones N, Chao PH, Chan V, Hohenwarter L, Wu A, Bergamo M, Rodríguez-Rodríguez C, Saatchi K, Liang A, Häfeli UO, Tan Z, Hedtrich S, Andrew LJ, Li SD
Biomaterials · 2024 · 308:122567
DOI
#46
2024123IDrug deliveryRadiochemistrySPECT

A Novel Leu-Enkephalin Prodrug Produces Pain-Relieving and Antidepressant Effects

Hohenwarter L, Puil E, Rouhollahi E, Bohrmann L, Lu S, Saatchi K, Häfeli UO, Barr A, Bottger R, DurgaRao Viswanadham KK, Li SD
Molecular Pharmaceutics · 2024 · 21(2):688–703
DOI
#45
2024CancerMethodsOpticalUS

Development of an Immunosuppressed Orthotopic Hepatocellular Carcinoma Rat Model for the Evaluation of Chemo- and Radioembolization Therapies

Charles L, Sekar S, Osooly M, Javed S, Williams KC, Welch I, Barta I, Saatchi K, Häfeli UO
European Journal of Pharmaceutics and Biopharmaceutics · 2024 · 196:114180
DOI
#44
202368GaPharmacokineticsMethodsPET

Preclinical PET Imaging and Toxicity Study of a 68Ga-Functionalized Polymeric Cardiac Blood Pool Agent

Saatchi K, Benard F, Hundal N, Grimes J, Shcherbinin S, Pourghiasian M, Brooks DE, Celler A, Häfeli UO
Pharmaceutics · 2023 · 15:767
DOI
#43
2023111InNanomedicineDrug deliverySPECT

Pulmonary delivery of siRNA-loaded lipid-polymer hybrid nanoparticles: Effect of nanoparticle size

Wadhwa A, Bobak TR, Bohrmann L, Geczy R, Sekar S, Sathyanarayanan G, Kutter JP, Franzyk H, Foged C, Saatchi K, Häfeli UO
OpenNano · 2023 · 13:100180
DOI
#42
2023225Ac155TbTheranosticsRadiochemistrySPECT

Rearmed Bifunctional Chelating Ligand for 225Ac/155Tb Precision-Guided Theranostic Radiopharmaceuticals─H4noneunpaX

Wharton L, Yang H, Jaraquemada-Peláez M de G, Merkens H, Engudar G, Ingham A, Koniar H, Radchenko V, Kunz P, Schaffer P, Bénard F, Orvig C
Journal of Medicinal Chemistry · 2023 · 66(19):13705–13730
DOI
#41
2023111InNanomedicineCancerMethodsSPECT

Quantitative Evaluation of a Multimodal Aptamer-Targeted Long-Circulating Polymer for Tumor Targeting

Bohrmann L, Burghardt T, Rodríguez-Rodríguez C, Herth MM, Saatchi K, Häfeli UO
ACS Omega · 2023
DOI
#40
2023155Tb161TbTheranosticsCancerRadiochemistrySPECT

Preclinical evaluation of [155/161Tb]Tb-Crown-TATE — A novel SPECT imaging theranostic agent targeting neuroendocrine tumours

Wharton L, McNeil SW, Merkens H, Yuan Z, Van de Voorde M, Engudar G, Ingham A, Koniar H, Rodríguez-Rodríguez C, Radchenko V, Ooms M, Kunz P, Bénard F, Schaffer P, Yang H
Molecules · 2023 · 28(7):3155
DOI
#39
2022111InTheranosticsMethodsMRIOpticalSPECTUSCT

Aptamers used for molecular imaging and theranostics — recent developments

Bohrmann L, Burghardt T, Haynes C, Saatchi K, Häfeli UO
Theranostics · 2022 · 12:4010–4050
DOI
#38
202299mTcDrug deliveryMethodsOpticalSPECT

Potential of Nuclear Imaging Techniques to Study the Oral Delivery of Peptides

Saxena T, Sie C, Lin K, Ye D, Saatchi K, Häfeli UO
Pharmaceutics · 2022 · 14:2809
DOI
#37
2022225Ac111InTheranosticsRadiochemistrySPECT

H4picoopa ─ Robust Chelate for 225Ac/111In Theranostics

Wharton L, Jaraquemada-Peláez M de G, Zhang C, Zeisler J, Rodríguez-Rodríguez C, Osooly M, Radchenko V, Yang H, Lin KS, Bénard F, Schaffer P, Orvig C
Bioconjugate Chemistry · 2022 · 33(10):1900–1921
DOI
#36
202267GaAntimicrobialPharmacokineticsSPECT

Biodistribution and toxicity of innate defense regulator 1018 (IDR-1018)

Esposito TVF, Rodríguez-Rodríguez C, Blackadar C, Haney EF, Pletzer D, Hancock REW, Saatchi K, Häfeli UO
European Journal of Pharmaceutics and Biopharmaceutics · 2022 · 179:11–25
DOI
#35
2022225Ac226AcTheranosticsMethodsSPECT

SPECT imaging of 226Ac as a theranostic isotope for 225Ac radiopharmaceutical development

Koniar H, Rodríguez-Rodríguez C, Radchenko V, Yang H, Kunz P, Rahmim A, Uribe C, Schaffer P
Physics in Medicine and Biology · 2022 · 67(18):185009
DOI
#34
2022111AgAntimicrobialNanomedicineSPECT

SPECT/CT Imaging of 111Ag for the Preclinical Evaluation of Silver-Based Antimicrobial Nanomedicines

Blackadar C, Choi K-Y G, Embree MF, Hennkens HM, Rodríguez-Rodríguez C, Hancock REW, Saatchi K, Häfeli UO
ACS Applied Materials & Interfaces · 2022 · 14(23):26382–26393
DOI
#33
2022213Bi111InTheranosticsCancerRadiochemistrySPECT

[213Bi]Bi3+/[111In]In3+-neunpa-cycMSH: Theranostic Radiopharmaceutical Targeting Melanoma ─ Structural, Radiochemical, and Biological Evaluation

Wharton L, Zhang C, Yang H, Zeisler J, Radchenko V, Rodríguez-Rodríguez C, Ossoly M, Patrick OB, Lin KS, Bénard F, Schaffer P, Orvig C
Bioconjugate Chemistry · 2022 · 33(3):505–522
DOI
#32
2022225Ac111InTheranosticsRadiochemistrySPECT

H3TPAN-Triazole-Bn-NH2: Tripicolinate Clicked-Bifunctional Chelate for [225Ac]/[111In] Theranostics

Wharton L, Zhang C, Zeisler J, Rodríguez-Rodríguez C, Osooly M, Radchenko V, Yang H, Lin KS, Bénard F, Schaffer P, Orvig C
Bioconjugate Chemistry · 2022 · 33(12):2381–2397
DOI
#31
2022111InDrug deliveryPharmacokineticsSPECT

Metal-ion coordinated self-assembly of human insulin directs kinetics of insulin release as determined by preclinical SPECT/CT imaging

Engudar G, Rodríguez-Rodríguez C, Mishra NK, Bergamo M, Amouroux G, Jensen KJ, Saatchi K, Häfeli UO
Journal of Controlled Release · 2022 · 343:347–360
DOI
#30
2021177LuTheranosticsCancerNanomedicine

Electron microscopy of antibody-conjugated, lutetium-177 lanthanide gold-coated nanoparticles: Proof of concept of targeted loci—A potential theranostic agent

Kogos B, Cohen-Gould L, Rodríguez-Rodríguez C, Sossi V, Sobol N, Johnson R, Miller DC, Robertson JD, Pevsner PH
AIP Advances · 2021 · 11(4):045035
DOI
#29
2021MethodsCT

Comparison of Rhenium and Iodine as Contrast Agents in X-Ray Imaging

de la Vega JC, Esquinas PL, Gill JK, Jessa S, Gill B, Thakur Y, Saatchi K, Häfeli UO
Contrast Media & Molecular Imaging · 2021 · 1250360
DOI
#28
2021123I125IMethodsDrug deliverySPECTDual tracer

Simultaneous SPECT imaging with 123I and 125I — a practical approach to assessing a drug and its carrier at the same time with dual imaging

Nosrati Z, Esquinas PL, Rodríguez-Rodríguez C, Tran T, Maharaj A, Saatchi K, Häfeli UO
International Journal of Pharmaceutics · 2021 · 606:120884
DOI
#27
2021111InNanomedicineDrug delivery

Poly(lactide-co-glycolide) Nanoparticles Mediate Sustained Gene Silencing and Improved Biocompatibility of siRNA Delivery Systems in Mouse Lungs after Pulmonary Administration

Wu L, Wu LP, Wu J, Sun J, He Z, Rodríguez-Rodríguez C, Saatchi K, Dailey LA, Häfeli UO, Dongmei C, Mingshi Y
ACS Applied Materials & Interfaces · 2021 · 13:3722–3737
DOI
#26
2021111InMethods

Preparation of Heat-Denatured Macroaggregated Albumin for Biomedical Applications Using a Microfluidics Platform

Esposito TVF, Stütz H, Rodríguez-Rodríguez C, Bergamo M, Charles L, Geczy R, Saatchi K, Häfeli UO
ACS Biomaterials Science & Engineering · 2021 · 7(6):2823–2834
DOI
#25
2021111In64CuNanomedicineImagingPETSPECT

Hybrid Metal–Phenol Nanoparticles with Polydopamine-like Coating for PET/SPECT/CT Imaging

Suárez-García S, Esposito TVF, Neufeld-Peters J, Bergamo M, Yang H, Saatchi K, Schaffer P, Häfeli UO, Ruiz-Molina D, Rodríguez-Rodríguez C, Novio F
ACS Applied Materials & Interfaces · 2021 · 13:10705–10718
DOI
#24
2020InflammationMethodsIR

Refinement and validation of infrared thermal imaging (IRT): a non-invasive technique to measure disease activity in a mouse model of rheumatoid arthritis

Nosrati Z, Bergamo M, Rodríguez-Rodríguez C, Saatchi K, Häfeli UO
2020
DOI
#23
2020111InDrug deliveryPharmacokineticsSPECTCT

Bioimaging and Biodistribution of the Metal-Ion-Controlled Self-Assembly of PYY3-36 Studied by SPECT/CT

Kalomoiri P, Rodríguez-Rodríguez C, Sørensen KK, Bergamo M, Saatchi K, Häfeli UO, Jensen KJ
ChemBioChem · 2020 · 248
DOI
#22
2020225AcTheranosticsRadiochemistryCancer

Synthesis and Evaluation of a Macrocyclic Actinium-225 Chelator, Quality Control and In Vivo Evaluation of 225Ac-crown-αMSH Peptide

Yang H, Zhang C, Yuan Z, Rodríguez-Rodríguez C, Robertson A, Radchenko V, Perron R, Gendron D, Causey P, Gao F, Bénard F, Schaffer P
Chemistry – A European Journal · 2020 · 26(50):11435–11440
DOI
#21
202067Ga68GaRadiochemistryPET

H2CHXhox: Rigid Cyclohexane-Reinforced Nonmacrocyclic Chelating Ligand for [nat/67/68Ga]Ga3+

Wang X, Jaraquemada-Peláez M de G, Cao Y, Ingham A, Rodríguez-Rodríguez C, Pan J, Wang Y, Saatchi K, Häfeli UO, Lin K-S, Orvig C
Inorganic Chemistry · 2020 · 59(7):4895–4908
DOI
#20
2020111InNanomedicineDrug deliveryPharmacokineticsSPECT

Monosized Polymeric Microspheres Designed for Passive Lung Targeting: Biodistribution and Pharmacokinetics after Intravenous Administration

Agnoletti M, Rodríguez-Rodríguez C, Klodzinska SN, Esposito TVF, Saatchi K, Nielsen HM, Häfeli UO
ACS Nano · 2020 · 14:6693–6706
DOI
#19
2020111InNanomedicineDrug deliveryMethodsSPECT

Quantitative comparison of three widely-used pulmonary administration methods in vivo with radiolabeled inhalable nanoparticles

Wu L, Rodríguez-Rodríguez C, Cun D, Yang M, Saatchi K, Häfeli UO
European Journal of Pharmaceutics and Biopharmaceutics · 2020 · 152:108–115
DOI
#18
2020125I123IDrug deliveryPharmacokineticsSPECTDual tracer

Using in vitro lipolysis and SPECT/CT in vivo imaging to understand oral absorption of fenofibrate from lipid-based drug delivery systems

Tran T, Bønløkke P, Rodríguez-Rodríguez C, Nosrati Z, Esquinas PL, Borkar N, Plum J, Strindberg S, Karagiozov S, Rades T, Müllertz A, Saatchi K, Häfeli UO
Journal of Controlled Release · 2020 · 317:375–384
DOI
#17
201989ZrRadiochemistryPharmacokineticsPET

Evaluation of the Tetrakis(3-Hydroxy-4-Pyridinone) Ligand THPN with Zirconium(IV): Thermodynamic Solution Studies, Bifunctionalization, and in Vivo Assessment of Macromolecular 89Zr-THPN-Conjugates

Buchwalder C, Jaraquemada-Peláez M de G, Rousseau J, Merkens H, Rodríguez-Rodríguez C, Orvig C, Bénard F, Schaffer P, Saatchi K, Häfeli UO
Inorganic Chemistry · 2019 · 58(21):14667–14681
DOI
#16
2019225AcTheranosticsCancerRadiochemistry

Evaluation of polydentate picolinic acid chelating ligands and an α-melanocyte-stimulating hormone derivative for targeted alpha therapy using ISOL-produced 225Ac

Ramogida CF, Robertson AKH, Jermilova U, Zhang C, Yang H, Kunz P, Lassen J, Bratanovic I, Brown V, Southcott L, Rodríguez-Rodríguez C, Radchenko V, Bénard F, Orvig C, Schaffer P
EJNMMI Radiopharmacy and Chemistry · 2019
DOI
#15
2019188ReCancerTheranosticsMethodsSPECT

Radioembolization of Hepatocellular Carcinoma with Built-In Dosimetry: First In Vivo Results with Uniformly-Sized, Biodegradable Microspheres Labeled with 188Re

de la Vega J, Esquinas PL, Rodríguez-Rodríguez C, Bokharaei M, Moskalev I, Liu D, Saatchi K, Häfeli UO
Theranostics · 2019 · 9:868–883
DOI
#14
2018111In67GaAntimicrobialDrug deliverySPECTCTDual tracer

Dual-Isotope SPECT/CT Imaging of the Tuberculosis Subunit Vaccine H56/CAF01: Induction of Strong Systemic and Mucosal IgA and T-Cell Responses on Mice Upon Subcutaneous Prime and Intrapulmonary Boost Immunization

Thakur A, Rodríguez-Rodríguez C, Saatchi K, Rose F, Esposito T, Nosrati Z, Andersen P, Christensen D, Häfeli UO, Foged C
Frontiers in Immunology · 2018 · 9:2825
DOI
#13
2018111In67GaMethodsPharmacokineticsSPECTDual tracer

Dual SPECT Imaging of 111In and 67Ga to simultaneously Determine In Vivo the Pharmacokinetics of Different Radiopharmaceuticals: A Quantitative Tool in Preclinical Research

Esquinas P, Rodríguez-Rodríguez C, Esposito T, Saatchi K, Celler A, Sossi V, Häfeli UO
Physics in Medicine & Biology · 2018 · 63:235029
DOI
#12
2018111InRadiochemistrySPECT

H4octox: Versatile Bimodal Octadentate Acyclic Chelating Ligand for Medicinal Inorganic Chemistry

Wang X, Jaraquemada-Peláez M de G, Rodríguez-Rodríguez C, Cao Y, Buchwalder C, Choudhary N, Jermilova U, Ramogida CF, Saatchi K, Häfeli UO, Patrick BO, Orvig C
Journal of the American Chemical Society · 2018 · 140:15487–15500
DOI
#11
2018177LuTheranosticsCancerNanomedicineSPECT

Synthesis and targeting of gold-coated 177Lu-containing lanthanide phosphate nanoparticles — A potential theranostic agent for pulmonary metastatic disease

Sobol N, Sutherlin L, Cedrowska E, Schorp J, Rodríguez-Rodríguez C, Sossi V, Lattimer J, Miller DC, Pevsner P, Robertson JD
APL Bioengineering · 2018 · 2(1):016101
DOI
#10
2018209At211AtTheranosticsMethodsSPECT

Evaluation of 209At as a theranostic isotope for 211At-radiopharmaceutical development using high-energy SPECT

Crawford JR, Robertson AKH, Yang H, Rodríguez-Rodríguez C, Esquinas PL, Kunz P, Blinder S, Sossi V, Schaffer P, Ruth TJ
Physics in Medicine & Biology · 2018 · 63(4):045025
DOI
#9
201867GaNanomedicineCancerPharmacokineticsSPECT

Quantitative SPECT imaging and biodistribution point to molecular weight independent tumor uptake for some long-circulating polymer nanocarriers

Schmitt V, Rodríguez-Rodríguez C, Hamilton JL, Shenoi RA, Schaffer P, Sossi V, Kizhakkedathu JN, Saatchi K, Häfeli UO
RSC Advances · 2018 · 8(10):5586–5595
DOI
#8
2017225AcTheranosticsRadiochemistry

An Eighteen-Membered Macrocyclic Ligand for Actinium-225 Targeted Alpha Therapy

Thiele NA, Brown V, Kelly JM, Amor-Coarasa A, Jermilova U, MacMillan SN, Nikolopoulou A, Ponnala S, Ramogida CF, Robertson AKH, Rodríguez-Rodríguez C, Schaffer P, Williams C Jr, Babich JW, Radchenko V, Wilson JJ
Angewandte Chemie International Edition · 2017 · 56(46):14712–14717
DOI
#7
201789ZrRadiochemistryPET

A new tetrapodal 3-hydroxy-4-pyridinone ligand for complexation of 89zirconium for positron emission tomography (PET) imaging

Buchwalder C, Rodríguez-Rodríguez C, Schaffer P, Karagiozov SK, Saatchi K, Häfeli UO
Dalton Transactions · 2017 · 46(29):9654–9663
DOI
#6
2017188ReTheranosticsMethodsSPECTCT

Accuracy of Rhenium-188 SPECT/CT activity quantification for applications in radionuclide therapy using clinical reconstruction methods

Esquinas P, Uribe C, Gonzales M, Rodríguez-Rodríguez C, Häfeli UO, Celler A
Physics in Medicine & Biology · 2017 · 62:6379–6396
DOI
#5
2017188ReMethodsImagingSPECT

188Re image performance assessment using small animal multi-pinhole SPECT/PET/CT system

Esquinas PL, Rodríguez-Rodríguez C, De La Vega JC, Bokharaei M, Saatchi K, Shirmohammad M, Häfeli UO, Sossi V, Celler A
Physica Medica · 2017 · 33:26–37
DOI
#4
2017225AcTheranosticsMethods

Multi-isotope SPECT imaging of the 225Ac decay chain: feasibility studies

Robertson AKH, Ramogida CF, Rodríguez-Rodríguez C, Blinder S, Kunz P, Sossi V, Schaffer P
Physics in Medicine & Biology · 2017 · 62(11):4406
DOI
#3
2017NanomedicineDrug delivery

Characterization of Alendronic- and Undecylenic Acid Coated Magnetic Nanoparticles for the Targeted Delivery of Rosiglitazone to Subcutaneous Adipose Tissue

Saatchi K, Tod SE, Leung D, Nicholson KE, Andreu I, Buchwalder C, Schmitt V, Häfeli UO
Nanomedicine: Nanotechnology, Biology, and Medicine · 2017 · 13(2):559–568
DOI
#2
2016188ReMethodsImaging

Accuracy, Reproducibility and Uncertainty Analysis of Thyroid Probe-Based Activity Measurements for Determination of Dose Calibrator Settings

Esquinas P, Tanguay JF, Gonzalez M, Vuckovic M, Rodríguez-Rodríguez C, Häfeli UO, Celler A
Medical Physics · 2016 · 43(12):6309–6321
DOI
#1
201418FMethodsImagingPETSPECT

Performance Assessment of a Preclinical PET Scanner with Pinhole Collimation by Comparison to a Coincidence-Based Small-Animal PET Scanner

Walker M, Goorden M, Dinelle K, Ramakers R, Blinder S, Shirmohammad M, van der Have F, Beekman F, Sossi V
Journal of Nuclear Medicine · 2014 · 55(8):1368–1374
DOI